Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
68.01B | 64.82B | 69.07B | 67.44B | 67.81B | Gross Profit |
15.41B | 14.09B | 15.05B | 14.73B | 13.97B | EBIT |
4.32B | 3.98B | 5.18B | 4.58B | 4.26B | EBITDA |
10.88B | 6.98B | 8.75B | 7.81B | 6.96B | Net Income Common Stockholders |
5.38B | 2.59B | 3.67B | 3.13B | 2.87B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
25.28B | 18.36B | 18.62B | 17.26B | 15.04B | Total Assets |
64.44B | 61.62B | 59.79B | 61.61B | 57.21B | Total Debt |
4.75B | 5.93B | 8.11B | 10.34B | 9.67B | Net Debt |
-20.52B | -10.71B | -8.75B | -5.03B | -3.53B | Total Liabilities |
24.67B | 24.26B | 26.36B | 30.19B | 29.34B | Stockholders Equity |
37.28B | 34.98B | 31.19B | 29.41B | 26.01B |
Cash Flow | Free Cash Flow | |||
2.98B | 3.40B | 5.21B | 2.00B | 2.20B | Operating Cash Flow |
5.31B | 4.99B | 6.83B | 6.84B | 5.04B | Investing Cash Flow |
6.33B | -788.01M | -2.03B | -4.44B | -3.01B | Financing Cash Flow |
-2.87B | -3.46B | -3.58B | -664.82M | 427.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $510.42B | 25.04 | 34.91% | 1.86% | 15.40% | 30.51% | |
72 Outperform | ¥582.75B | 21.38 | 2.16% | 5.75% | 1.41% | ||
71 Outperform | ¥27.21B | 15.58 | 3.62% | 5.74% | -13.48% | ||
68 Neutral | ¥175.53B | 22.46 | 2.91% | 5.20% | 88.69% | ||
67 Neutral | ¥32.54B | 4.50 | ― | 3.76% | -15.66% | ||
66 Neutral | ¥37.64B | 11.62 | 2.33% | 5.01% | -39.80% | ||
64 Neutral | $4.30B | 11.84 | 5.23% | 249.82% | 4.06% | -10.21% |